BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37821692)

  • 21. Succinate-Dehydrogenase Deficient Paragangliomas/Pheochromocytomas: Genetics, Clinical Aspects and Mini- Review.
    Rusyn L; Kohn B
    Pediatr Endocrinol Rev; 2017 Mar; 14(3):312-325. PubMed ID: 28508602
    [No Abstract]   [Full Text] [Related]  

  • 22. Pheochromocytoma associated with a succinate dehydrogenase subunit B mutation: A minireview and a case report.
    Rezkallah E; Elsaify A; Martin V; Viva L; Nag S; Green B; Cheesman M; Elsaify W
    Endocr Regul; 2023 Jan; 57(1):121-127. PubMed ID: 37285461
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes.
    Benn DE; Gimenez-Roqueplo AP; Reilly JR; Bertherat J; Burgess J; Byth K; Croxson M; Dahia PL; Elston M; Gimm O; Henley D; Herman P; Murday V; Niccoli-Sire P; Pasieka JL; Rohmer V; Tucker K; Jeunemaitre X; Marsh DJ; Plouin PF; Robinson BG
    J Clin Endocrinol Metab; 2006 Mar; 91(3):827-36. PubMed ID: 16317055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sporadic paraganglioma caused by de novo SDHB mutations in a 6-year-old girl.
    Imamura H; Muroya K; Tanaka E; Konomoto T; Moritake H; Sato T; Kimura N; Takekoshi K; Nunoi H
    Eur J Pediatr; 2016 Jan; 175(1):137-41. PubMed ID: 26283294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Germline SDHB mutations are common in patients with apparently sporadic sympathetic paragangliomas.
    Klein RD; Jin L; Rumilla K; Young WF; Lloyd RV
    Diagn Mol Pathol; 2008 Jun; 17(2):94-100. PubMed ID: 18382370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Succinate: A Serum Biomarker of SDHB-Mutated Paragangliomas and Pheochromocytomas.
    Lamy C; Tissot H; Faron M; Baudin E; Lamartina L; Pradon C; Al Ghuzlan A; Leboulleux S; Perfettini JL; Paci A; Hadoux J; Broutin S
    J Clin Endocrinol Metab; 2022 Sep; 107(10):2801-2810. PubMed ID: 35948272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. De novo SDHB gene mutation in a family with extra-adrenal paraganglioma.
    Mauer CB; Reys B; Wickiser J
    Fam Cancer; 2020 Jul; 19(3):269-271. PubMed ID: 32200538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of SDHB Elevates Catecholamine Synthesis and Secretion Depending on ROS Production and HIF Stabilization.
    Saito Y; Ishii KA; Aita Y; Ikeda T; Kawakami Y; Shimano H; Hara H; Takekoshi K
    Neurochem Res; 2016 Apr; 41(4):696-706. PubMed ID: 26620190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metastatic pheochromocytoma/paraganglioma related to primary tumor development in childhood or adolescence: significant link to SDHB mutations.
    King KS; Prodanov T; Kantorovich V; Fojo T; Hewitt JK; Zacharin M; Wesley R; Lodish M; Raygada M; Gimenez-Roqueplo AP; McCormack S; Eisenhofer G; Milosevic D; Kebebew E; Stratakis CA; Pacak K
    J Clin Oncol; 2011 Nov; 29(31):4137-42. PubMed ID: 21969497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Candidate gene mutation analysis in bilateral adrenal pheochromocytoma and sympathetic paraganglioma.
    Korpershoek E; Petri BJ; van Nederveen FH; Dinjens WN; Verhofstad AA; de Herder WW; Schmid S; Perren A; Komminoth P; de Krijger RR
    Endocr Relat Cancer; 2007 Jun; 14(2):453-62. PubMed ID: 17639058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phaeochromocytoma: a catecholamine and oxidative stress disorder.
    Pacak K
    Endocr Regul; 2011 Apr; 45(2):65-90. PubMed ID: 21615192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The penetrance of paraganglioma and pheochromocytoma in SDHB germline mutation carriers.
    Rijken JA; Niemeijer ND; Jonker MA; Eijkelenkamp K; Jansen JC; van Berkel A; Timmers HJLM; Kunst HPM; Bisschop PHLT; Kerstens MN; Dreijerink KMA; van Dooren MF; van der Horst-Schrivers ANA; Hes FJ; Leemans CR; Corssmit EPM; Hensen EF
    Clin Genet; 2018 Jan; 93(1):60-66. PubMed ID: 28503760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor risks and genotype-phenotype-proteotype analysis in 358 patients with germline mutations in SDHB and SDHD.
    Ricketts CJ; Forman JR; Rattenberry E; Bradshaw N; Lalloo F; Izatt L; Cole TR; Armstrong R; Kumar VK; Morrison PJ; Atkinson AB; Douglas F; Ball SG; Cook J; Srirangalingam U; Killick P; Kirby G; Aylwin S; Woodward ER; Evans DG; Hodgson SV; Murday V; Chew SL; Connell JM; Blundell TL; Macdonald F; Maher ER
    Hum Mutat; 2010 Jan; 31(1):41-51. PubMed ID: 19802898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quality of life is decreased in patients with paragangliomas.
    van Hulsteijn LT; Louisse A; Havekes B; Kaptein AA; Jansen JC; Hes FJ; Smit JW; Corssmit EP
    Eur J Endocrinol; 2013 May; 168(5):689-97. PubMed ID: 23392211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SDH mutations in tumorigenesis and inherited endocrine tumours: lesson from the phaeochromocytoma-paraganglioma syndromes.
    Pasini B; Stratakis CA
    J Intern Med; 2009 Jul; 266(1):19-42. PubMed ID: 19522823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High prevalence of occult paragangliomas in asymptomatic carriers of SDHD and SDHB gene mutations.
    Heesterman BL; Bayley JP; Tops CM; Hes FJ; van Brussel BT; Corssmit EP; Hamming JF; van der Mey AG; Jansen JC
    Eur J Hum Genet; 2013 Apr; 21(4):469-70. PubMed ID: 22948026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel mutation (L157X) in the succinate dehydrogenase B gene (SDHB) in a Japanese family with abdominal paraganglioma following lung metastasis.
    Saito T; Saito Y; Matsumura K; Tsubota Y; Maniwa T; Kaneda H; Minami K; Sakaida N; Uemura Y; Kawa G; Yamamoto N; Fujii Y; Isobe K; Kawakami Y; Matsuda T; Takekoshi K
    Endocr J; 2009; 56(3):451-8. PubMed ID: 19261994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The phenotype of
    Niemeijer ND; Rijken JA; Eijkelenkamp K; van der Horst-Schrivers ANA; Kerstens MN; Tops CMJ; van Berkel A; Timmers HJLM; Kunst HPM; Leemans CR; Bisschop PH; Dreijerink KMA; van Dooren MF; Bayley JP; Pereira AM; Jansen JC; Hes FJ; Hensen EF; Corssmit EPM
    Eur J Endocrinol; 2017 Aug; 177(2):115-125. PubMed ID: 28490599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Higher risk of phaeochromocytoma/paraganglioma (Phaeo-Pgl) in SDHD than SDHB carriers: an Australian cohort study.
    Hong A; Shanahan M; Schenberg T; Inder W; MacIsaac R; James P; Sachithanandan N
    Intern Med J; 2019 Apr; 49(4):529-532. PubMed ID: 30957378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Familial malignant catecholamine-secreting paraganglioma with prolonged survival associated with mutation in the succinate dehydrogenase B gene.
    Young AL; Baysal BE; Deb A; Young WF
    J Clin Endocrinol Metab; 2002 Sep; 87(9):4101-5. PubMed ID: 12213855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.